Research & Discovery

Headed by Gordon Mills and Rehan Akbanie, the MD Anderson GCC will use reverse phase protein arrays to investigate tumor tissue from a variety of NCI projects.

The effort will use Biognosys' HRM method to complement its MALDI-TOF approach to biomarker work, a company official said.

In studies, researchers have found that the BRD4-NUT oncoprotein affects megadomains and drives abnormal transcription that likely leads to NUT midline cancer.

The method detects somatic copy number alterations in whole-exome datasets without requiring input from users and irrespective of sequencing platform. 

The funds will support a multi-center clinical study investigating the test's usefulness in diagnosing elderly patients with lower respiratory tract infections.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."

Sep
10
Sponsored by
Qiagen

In this online seminar, Jo Vandesompele of the Center for Medical Genetics at Ghent University will discuss methods for improving the analysis of microRNA expression from a range of samples.